These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
176 related items for PubMed ID: 8630896
1. Molecular and immunohistochemical p53 status in liposarcoma and malignant fibrous histiocytoma: identification of seven new mutations for soft tissue sarcomas. Taubert H, Würl P, Meye A, Berger D, Thamm B, Neumann K, Hinze R, Schmidt H, Rath FW. Cancer; 1995 Oct 01; 76(7):1187-96. PubMed ID: 8630896 [Abstract] [Full Text] [Related]
2. Beta-catenin accumulation and gene mutation in exon 3 in dedifferentiated liposarcoma and malignant fibrous histiocytoma. Sakamoto A, Oda Y, Adachi T, Saito T, Tamiya S, Iwamoto Y, Tsuneyoshi M. Arch Pathol Lab Med; 2002 Sep 01; 126(9):1071-8. PubMed ID: 12204056 [Abstract] [Full Text] [Related]
3. Retroperitoneal liposarcoma with combined well-differentiated and myxoid malignant fibrous histiocytoma-like myxoid areas. Hisaoka M, Morimitsu Y, Hashimoto H, Ishida T, Mukai H, Satoh H, Motoi T, Machinami R. Am J Surg Pathol; 1999 Dec 01; 23(12):1480-92. PubMed ID: 10584701 [Abstract] [Full Text] [Related]
4. p53 gene mutations and p53 protein expression in human soft tissue sarcomas. Yoo J, Lee HK, Kang CS, Park WS, Lee JY, Shim SI. Arch Pathol Lab Med; 1997 Apr 01; 121(4):395-9. PubMed ID: 9140310 [Abstract] [Full Text] [Related]
5. Analysis of germline and tumor mutations of p53 gene in familial occurrence of soft tissue sarcomas. Kudawara I, Matsumine A, Ohzono K. J Surg Oncol; 2007 Mar 15; 95(4):347-50. PubMed ID: 17192950 [Abstract] [Full Text] [Related]
6. p53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas. Wadayama B, Toguchida J, Yamaguchi T, Sasaki MS, Yamamuro T. Br J Cancer; 1993 Dec 15; 68(6):1134-9. PubMed ID: 8260365 [Abstract] [Full Text] [Related]
7. No correlation of c-myc overexpression and p53 mutations in liposarcomas. Schneider-Stock R, Walter H, Rys J, Radig K, Hoang-Vu C, Roessner A. Virchows Arch; 1998 Oct 15; 433(4):315-21. PubMed ID: 9808433 [Abstract] [Full Text] [Related]
8. Analysis of p53 and mdm2 proteins in malignant fibrous histiocytoma in absence of gene alteration: prognostic significance. Molina P, Pellín A, Navarro S, Boix J, Carda C, Llombart-Bosch A. Virchows Arch; 1999 Dec 15; 435(6):596-605. PubMed ID: 10628802 [Abstract] [Full Text] [Related]
9. p53 Mutation and MDM2 amplification in human soft tissue sarcomas. Leach FS, Tokino T, Meltzer P, Burrell M, Oliner JD, Smith S, Hill DE, Sidransky D, Kinzler KW, Vogelstein B. Cancer Res; 1993 May 15; 53(10 Suppl):2231-4. PubMed ID: 8387391 [Abstract] [Full Text] [Related]
10. H-ras oncogene mutation in dedifferentiated liposarcoma. Polymerase chain reaction-restriction fragment length polymorphism analysis. Sakamoto A, Oda Y, Adachi T, Tamiya S, Matsuda S, Tanaka K, Iwamoto Y, Tsuneyoshi M. Am J Clin Pathol; 2001 Feb 15; 115(2):235-42. PubMed ID: 11211612 [Abstract] [Full Text] [Related]
11. Immunoexpression of ultraviolet photoproducts and p53 mutation analysis in atypical fibroxanthoma and superficial malignant fibrous histiocytoma. Sakamoto A, Oda Y, Itakura E, Oshiro Y, Nikaido O, Iwamoto Y, Tsuneyoshi M. Mod Pathol; 2001 Jun 15; 14(6):581-8. PubMed ID: 11406660 [Abstract] [Full Text] [Related]
12. A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in soft-tissue sarcomas. Rieske P, Bartkowiak JK, Szadowska AM, Olborski B, Harezga-Bal B, Debiec-Rychter M. J Exp Clin Cancer Res; 1999 Sep 15; 18(3):403-16. PubMed ID: 10606188 [Abstract] [Full Text] [Related]
13. MDM2 amplification, P53 mutation, and accumulation of the P53 gene product in malignant fibrous histiocytoma. Reid AH, Tsai MM, Venzon DJ, Wright CF, Lack EE, O'Leary TJ. Diagn Mol Pathol; 1996 Mar 15; 5(1):65-73. PubMed ID: 8919547 [Abstract] [Full Text] [Related]
14. Myxoid malignant fibrous histiocytoma and pleomorphic liposarcoma share very similar genomic imbalances. Idbaih A, Coindre JM, Derré J, Mariani O, Terrier P, Ranchère D, Mairal A, Aurias A. Lab Invest; 2005 Feb 15; 85(2):176-81. PubMed ID: 15702084 [Abstract] [Full Text] [Related]
15. Reassessment and clinicopathological prognostic factors of malignant fibrous histiocytoma of soft parts. Oda Y, Tamiya S, Oshiro Y, Hachitanda Y, Kinukawa N, Iwamoto Y, Tsuneyoshi M. Pathol Int; 2002 Sep 15; 52(9):595-606. PubMed ID: 12406189 [Abstract] [Full Text] [Related]
16. Histiocyte-like cells expressing factor XIIIa do not belong to the neoplastic cell population in malignant fibrous histiocytoma. Szollosi Z, Nemeth T, Egervari K, Nemes Z. Pathol Res Pract; 2005 Sep 15; 201(5):369-77. PubMed ID: 16047946 [Abstract] [Full Text] [Related]
17. p53 gene mutations in soft-tissue sarcomas--correlations with p53 immunohistochemistry and DNA ploidy. Schneider-Stock R, Radig K, Oda Y, Mellin W, Rys J, Niezabitowski A, Roessner A. J Cancer Res Clin Oncol; 1997 Sep 15; 123(4):211-8. PubMed ID: 9177493 [Abstract] [Full Text] [Related]
18. Reverse transcriptase-polymerase chain reaction amplification of MDR1 gene expression in adult soft tissue sarcomas. Oda Y, Schneider-Stock R, Ryś J, Gruchała A, Niezabitowski A, Roessner A. Diagn Mol Pathol; 1996 Jun 15; 5(2):98-106. PubMed ID: 8727096 [Abstract] [Full Text] [Related]
19. p53 immunohistochemistry in malignant fibrous histiocytomas and other mesenchymal tumours. Soini Y, Vähäkangas K, Nuorva K, Kamel D, Lane DP, Pääkkö P. J Pathol; 1992 Sep 15; 168(1):29-33. PubMed ID: 1333524 [Abstract] [Full Text] [Related]
20. Gene expression analysis of soft tissue sarcomas: characterization and reclassification of malignant fibrous histiocytoma. Nakayama R, Nemoto T, Takahashi H, Ohta T, Kawai A, Seki K, Yoshida T, Toyama Y, Ichikawa H, Hasegawa T. Mod Pathol; 2007 Jul 15; 20(7):749-59. PubMed ID: 17464315 [Abstract] [Full Text] [Related] Page: [Next] [New Search]